Results 211 to 220 of about 1,591,440 (405)

STK25 Loss Augments Anti‐PD‐1 Therapy Efficacy by Regulating PD‐L1 Stability in Colorectal Cancer

open access: yesAdvanced Science, EarlyView.
This study demonstrates that STK25 depletion facilitates CRC immune escape through the inhibition of PD‐L1 Ser283 phosphorylation‐mediated ubiquitination, and promotes tumor growth. Furthermore, these findings identify STK25 as a potential therapeutic target to trigger antitumor immunity and promote immunotherapy efficacy. Abstract Tumor immune evasion
Xiaowen Qiao   +20 more
wiley   +1 more source

30S Ribosomal proteins associated with the 3′‐terminus of 16S RNA [PDF]

open access: bronze, 1975
A.P. Czernilofsky   +2 more
openalex   +1 more source

25 years of serving the community with ribosomal RNA gene reference databases and tools.

open access: yesJournal of Biotechnology, 2017
F. Glöckner   +10 more
semanticscholar   +1 more source

HPD is an RNA‐Binding Protein Sustaining Ovarian Cancer Cell Glycolysis, Tumor Growth, and Drug Resistance

open access: yesAdvanced Science, EarlyView.
HPD is identified as an RNA‐binding protein that promotes mRNA translation by binding to RRACH motifs via its double‐stranded RNA‐binding domains. This RNA‐binding activity critically sustains glycolysis in ovarian cancer cells. Disrupting HPD's RNA‐binding function effectively suppresses tumor growth and enhances therapeutic sensitivity, highlighting ...
Fei Xie   +21 more
wiley   +1 more source

Location and characteristics of ribosomal protein binding sites in the 16S RNA of Escherichia coli [PDF]

open access: green, 1975
René Zimmermann   +8 more
openalex   +1 more source

The ribosomal RNA Database project [PDF]

open access: yesNucleic Acids Research, 1991
Gary J. Olsen   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy